CD86 and neoplasm: MC-C tumor immunogenicity was associated with the capacity of MC-C tumor lysate to promote the maturation of DC as evaluated by the up-regulation of cell surface receptors CD80, CD86 and MHC II as well as production of the inflammatory cytokines TNF-α and IL-12p70 (Fig. 1B, C and D).